ACIP Panel Faces turbulence as RFK Jr. Advisers Prompt Vaccine Schedule Shifts
The Centers for Disease Control adn Prevention’s Advisory Committee on Immunization Practices (ACIP) is experiencing internal friction and a revised agenda following the appointment of individuals with vaccine skepticism, reportedly linked to Robert F. Kennedy Jr., to key positions within the Department of Health and Human Services (HHS). The panel’s recent deliberations, particularly regarding COVID-19 vaccinations for pregnant people and infants, have revealed deep divisions and a reluctance to reaffirm existing recommendations.
The shift in focus comes as the ACIP prepares to review a broad range of already-approved vaccines, including those for vulnerable populations. Public health experts have expressed alarm over the potential for anti-vaccine influence within HHS, raising concerns about the committee’s ability to maintain a science-driven approach to immunization policy. The ACIP’s upcoming meetings are expected to be contentious as members navigate the evolving landscape and address ongoing debates, such as the hepatitis B vaccine schedule.
During internal discussions, members of a working group reportedly debated recommending the COVID-19 shot for pregnant individuals and babies, with a majority initially leaning against it. Ultimately, the group opted not to vote on the matter. Dissenting members then presented data supporting vaccination for these groups,citing their vulnerability to the virus.
“Covid-19 vaccines are highly safe and effective. Or if we don’t want to say safe and effective, they work,” stated Henry Bernstein, a pediatrician and working group member.
ACIP member Dr. Melinda Levi acknowledged the scrutiny surrounding the group’s actions but defended its process. “I know there’s drama around every action the group is taking, but if you actually follow what we are doing, we are basically following our mission and doing it with a lot of engagement and I think in a very science-driven way,” she said.
The panel is scheduled to reconvene next month, with the possibility of revisiting the hepatitis B vaccine debate and continuing its review of vaccines for pregnant people. Levi indicated the ACIP will periodically “review every vaccine,” but did not specify which vaccines would be prioritized.
Matthew Herper and Anil Oza contributed reporting.
